172 related articles for article (PubMed ID: 27906766)
1. Prescription of Postexposure Prophylaxis for HIV-1 in the Emergency Room: Correct Transmission Risk Assessment Remains Challenging.
Marzel A; Heinrich H; Schilliger L; Fehr JS; Günthard HF; Kouyos R; Rampini SK
J Acquir Immune Defic Syndr; 2017 Apr; 74(4):359-366. PubMed ID: 27906766
[TBL] [Abstract][Full Text] [Related]
2. To prescribe, or not to prescribe: decision making in HIV-1 post-exposure prophylaxis.
Scholten M; Suárez I; Platten M; Kümmerle T; Jung N; Wyen C; Ernst A; Horn C; Burst V; Suárez V; Rybniker J; Fätkenheuer G; Lehmann C
HIV Med; 2018 Oct; 19(9):645-653. PubMed ID: 29993176
[TBL] [Abstract][Full Text] [Related]
3. Trends in HIV postexposure prophylaxis prescription and compliance after sexual exposure in Amsterdam, 2000-2004.
Sonder GJ; van den Hoek A; Regez RM; Brinkman K; Prins JM; Mulder JW; Veenstra J; Claessen FA; Coutinho RA
Sex Transm Dis; 2007 May; 34(5):288-93. PubMed ID: 16980918
[TBL] [Abstract][Full Text] [Related]
4. HIV Post-Exposure Prophylaxis (PEP) Awareness and Non-Occupational PEP (nPEP) Prescribing History Among U.S. Healthcare Providers.
John SA; Quinn KG; Pleuhs B; Walsh JL; Petroll AE
AIDS Behav; 2020 Nov; 24(11):3124-3131. PubMed ID: 32300991
[TBL] [Abstract][Full Text] [Related]
5. Prescribing practices in a population-based HIV postexposure prophylaxis program.
Braitstein P; Chan K; Beardsell A; McLeod A; Montaner JS; O'Shaughnessy MV; Hogg RS
AIDS; 2002 May; 16(7):1067-70. PubMed ID: 11953474
[TBL] [Abstract][Full Text] [Related]
6. HIV postexposure prophylaxis for children and adolescents.
Babl FE; Cooper ER; Damon B; Louie T; Kharasch S; Harris JA
Am J Emerg Med; 2000 May; 18(3):282-7. PubMed ID: 10830685
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
Merchant RC; Keshavarz R
Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
[TBL] [Abstract][Full Text] [Related]
8. Experiences of HIV postexposure prophylaxis (PEP) among highly exposed men who have sex with men (MSM).
Palich R; Martin-Blondel G; Cuzin L; Le Talec JY; Boyer P; Massip P; Delobel P
Sex Transm Infect; 2017 Nov; 93(7):493-498. PubMed ID: 28739808
[TBL] [Abstract][Full Text] [Related]
9. Dolutegravir with tenofovir disoproxil fumarate-emtricitabine as HIV postexposure prophylaxis in gay and bisexual men.
McAllister JW; Towns JM; Mcnulty A; Pierce AB; Foster R; Richardson R; Carr A
AIDS; 2017 Jun; 31(9):1291-1295. PubMed ID: 28301425
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of HIV postexposure prophylaxis for occupational and nonoccupational exposures at a deployed U.S. military trauma hospital.
Okulicz JF; Murray CK
Mil Med; 2012 Dec; 177(12):1524-32. PubMed ID: 23397700
[TBL] [Abstract][Full Text] [Related]
11. Post-exposure prophylaxis for human immunodeficiency virus after sexual assault in a Midwestern U.S. emergency department.
Cherabie JN; Gleason E; Munigala S; Fox B; Trolard A; McCammon C; Hilbert S; Casabar E; Reno H; Liang SY
Am J Emerg Med; 2021 Nov; 49():117-123. PubMed ID: 34102456
[TBL] [Abstract][Full Text] [Related]
12. Prescription of Non-Occupational Post-Exposure HIV Prophylaxis by Emergency Physicians: An Analysis on Accuracy of Prescription and Compliance.
Malinverni S; Libois A; Gennotte AF; La Morté C; Mols P
PLoS One; 2016; 11(4):e0153021. PubMed ID: 27070319
[TBL] [Abstract][Full Text] [Related]
13. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
U.S. Public Health Service
MMWR Recomm Rep; 2001 Jun; 50(RR-11):1-52. PubMed ID: 11442229
[TBL] [Abstract][Full Text] [Related]
14. [HIV post exposure prophylaxis therapy - the experience of two major AIDS centers].
Elbirt D; Levy I; Asher I; Mahlev-Guri K; Rosenberg-Bezalet S; Litachevsky S; Radian-Sade S; Sthoeger Z
Harefuah; 2013 Apr; 152(4):224-9, 246. PubMed ID: 23844525
[TBL] [Abstract][Full Text] [Related]
15. Assessment of HIV-postexposure prophylaxis prescription quality after a training programme and assistance in decisions provided by a computer-based decision program: a cross-over study.
Casalino E; Bouzid D; Antoniol S; Choquet C; Colosi L; Pereira L; Agbessi A; Kenway P; Yazdanpanah Y; Ghazali DA
Acta Clin Belg; 2022 Jun; 77(3):495-509. PubMed ID: 33783339
[TBL] [Abstract][Full Text] [Related]
16. High HIV incidence in men who have sex with men attending for postexposure prophylaxis: a service evaluation.
Whitlock G; McCormack C; Fearnley J; McOwan A
Sex Transm Infect; 2017 May; 93(3):214-216. PubMed ID: 27412954
[TBL] [Abstract][Full Text] [Related]
17. A Meta-Analysis of HIV Postexposure Prophylaxis Among Sexually Assaulted Patients in the United States.
Scannell M; Kim T; Guthrie BJ
J Assoc Nurses AIDS Care; 2018; 29(1):60-69. PubMed ID: 29174349
[TBL] [Abstract][Full Text] [Related]
18. Incidence of visits for health care worker blood or body fluid exposures and HIV postexposure prophylaxis provision at Rhode Island emergency departments.
Merchant RC; Chee KJ; Liu T; Mayer KH
J Acquir Immune Defic Syndr; 2008 Mar; 47(3):358-68. PubMed ID: 18176321
[TBL] [Abstract][Full Text] [Related]
19. Use of HIV pre-exposure prophylaxis during the preconception, antepartum and postpartum periods at two United States medical centers.
Seidman DL; Weber S; Timoney MT; Oza KK; Mullins E; Cohan DL; Wright RL
Am J Obstet Gynecol; 2016 Nov; 215(5):632.e1-632.e7. PubMed ID: 27448959
[TBL] [Abstract][Full Text] [Related]
20. The Danish PEP registry: experience with the use of postexposure prophylaxis (PEP) following sexual exposure to HIV from 1998 to 2006.
Lunding S; Katzenstein TL; Kronborg G; Lindberg JA; Jensen J; Nielsen HI; Pedersen C; Jørgensen LB
Sex Transm Dis; 2010 Jan; 37(1):49-52. PubMed ID: 19734819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
